Drug manufacturer Merck sent letters to 340B covered entities by email on Tuesday to provide background and answer questions about its request that entities voluntarily upload their contract pharmacy claims to a vendor’s software platform so they can be checked
…
The federal government on Monday strongly objected to letting six hospital groups participate as third parties in drug manufacturer Novo Nordisk’s lawsuit challenging the government’s 340B contract pharmacy requirements.
The government’s March 22 brief in opposition the groups’ motion
…
The federal judge considering drug manufacturer Sanofi’s motion for protection from 340B dispute resolution proceedings asked the company and the federal government last Wednesday to brief her on a different federal judge’s order the day before granting drug company Eli
…
Ryan White Clinics for 340B Access (RWC-340B) and the federal government have a deadline today to report to a federal judge about whether to continue the stay in the group’s suit to force the government to act against drug manufacturers
…
A few years ago, there was hope that congressional Democrats and Republicans and the Trump administration would unite and enact legislation addressing the high price of prescription drugs.
It never happened. House Democrats passed a far-ranging drug pricing bill in
…
The U.S. Health and Human Services Department (HHS) announced late this morning that it will delay, from this coming Monday, March 22 until July 20, the effective date of a Trump administration rule to require health centers to provide insulin
…
A bipartisan group of six U.S. senators on Tuesday reintroduced legislation from the last session of Congress to protect hospitals from losing eligibility for 340B drug discounts during the COVID-19 pandemic.
Five of the six types of hospitals that can
…
U.S. Sen. Bernie Sanders (I-Vt.) has scheduled a hearing next Tuesday of the U.S. Senate health subcommittee he chairs on why the United States pays the highest prices in the world for prescription drugs.
The Senate Health, Education, Labor, and
…
A federal judge’s decision to temporarily shield drug manufacturer Eli Lilly from the 340B program’s administrative dispute resolution (ADR) process could cause the government to issue 340B ADR regulations all over again, health care attorneys say.
U.S. District Judge Sarah
…
×
*Sign up for news summaries and alerts from 340B Report